Literature DB >> 31943245

Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats.

Daifei Wang1, Weibang Yu, Lin Cao1, Chuncao Xu1, Guoyao Tan1, Zhongxiang Zhao2, Min Huang1, Jing Jin1.   

Abstract

Salvia miltiorrhiza is one of the most commonly used traditional Chinese medicine in treatment of cardiovascular and cerebrovascular diseases. Cryptotanshinone (CTS), tanshinone IIA (Tan IIA), dihydrotanshinone I (diTan I), and tanshinone I (Tan I) are the main active compounds in the liposoluble extract of Salvia miltiorrhiza. The differences of the pharmacokinetic and tissue distribution behaviors of the four tanshinones after oral administration of the liposoluble extract of Salvia miltiorrhiza and pure compounds are not clear. This study aims to compare the pharmacokinetics and tissue distribution of the four tanshinones after oral administration of pure tanshinone monomers and the liposoluble extract of Salvia miltiorrhiza. An ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) analysis method was developed for determination of the four tanshinones. The results showed that the AUC and Cmax of tanshinones in rats receiving the extract of Salvia miltiorrhiza were significantly increased than those receiving the pure tanshinones. In the tissue distribution experiments, the AUC of the four tanshinones in the extract was much greater than the AUC of the monomers in the lung, heart, kidney, liver and brain, and the coexisting constituents particularly promoted the distribution of tanshinones into tissues that drug cannot sufficiently penetrated. These findings suggested that the coexisting constituents in the liposoluble extract of Salvia miltiorrhiza play an important role in the alteration of plasma concentration and tissue distribution of the four tanshinones. Understanding these differences could be of significance for the development and application of Salvia miltiorrhiza extract and tanshinone components. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  Salvia miltiorrhiza; Tanshinones; UPLC-MS/MS; bioavailability; pharmacokinetics; tissue distribution

Year:  2020        PMID: 31943245     DOI: 10.1002/bdd.2213

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  2 in total

1.  Mentha pulegium L. (Pennyroyal, Lamiaceae) Extracts Impose Abortion or Fetal-Mediated Toxicity in Pregnant Rats; Evidenced by the Modulation of Pregnancy Hormones, MiR-520, MiR-146a, TIMP-1 and MMP-9 Protein Expressions, Inflammatory State, Certain Related Signaling Pathways, and Metabolite Profiling via UPLC-ESI-TOF-MS.

Authors:  Amira A El-Gazar; Ayat M Emad; Ghada M Ragab; Dalia M Rasheed
Journal:  Toxins (Basel)       Date:  2022-05-16       Impact factor: 5.075

2.  Cryptotanshinone enhances the efficacy of Bcr-Abl tyrosine kinase inhibitors via inhibiting STAT3 and eIF4E signalling pathways in chronic myeloid leukaemia.

Authors:  Rubin Cheng; Yilan Huang; Yun Fang; Qirui Wang; Meixiu Yan; Yuqing Ge
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.